Public Attitudes Toward Genetic Risk Testing and Its Role in Healthcare

Holly Etchegary


Personalized Medicine. 2014;11(5):509-522. 

In This Article

Future Perspective

Genetic association studies will continue to reveal the genetic linkages to common, complex diseases, and WGS is moving into clinical practice at a steady pace.[10,15,16] Developments in pediatric screening technology, including WGS, will continue to challenge traditional notions of informed consent and parent education models.[3,77] These developments will necessitate continued public attitude and engagement research as healthcare professionals and policy makers grapple with translational issues surrounding emerging genomic technologies. It is likely that calls for stakeholder input will continue, particularly around WGS and the growing market of DTC tests. Such public opinion and engagement research are critical to allow informed public debate and input into the integration of genomic technologies to current healthcare systems in such a way that the health improvements suggested by personalized medicine can be realized.